RxSight, Inc. (RXST) ownership: insiders 10% · institutions 97% (13F 2026-03-31). Insider activity, 90 days: 4 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 3187092.00 | $19.63M | 7.7% | 2026-03-31 |
| Vanguard | 2291944.00 | $14.12M | 5.5% | 2026-03-31 |
| Millennium Management | 2059459.00 | $12.69M | 5.0% | 2026-03-31 |
| Artisan Partners | 2058684.00 | $12.68M | 5.0% | 2026-03-31 |
| Nomura | 2000060.00 | $12.32M | 4.8% | 2026-03-31 |
| No Street GP LP | 2000000.00 | $12.32M | 4.8% | 2026-03-31 |
| D. E. Shaw | 1959732.00 | $12.07M | 4.7% | 2026-03-31 |
| Defilade Capital Management, L.P. | 913090.00 | $9.51M | 2.2% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 |
Back to RXST overview · RXST earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.